Vincent Carlier
8Patents
2h-index
5Co-inventors
40Inventor score
Filing activity: Jun 6, 2005 → Jun 30, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10808016B2 | Peptides and methods for the treatment of diabetes | Human Necessities | 3 | Active |
| US10729791B2 | Animal models for evaluating pharmaceutical compounds | Human Necessities | 2 | Active |
| US11407795B2 | Peptides and methods for the treatment of diabetes | Human Necessities | 2 | Active |
| US11226332B2 | Method for the detection, preparation and depletion of CD4+ t lymphocytes | Physics | 2 | Active |
| US8199909B2 | Method and device for carrying out a cryptographic calculation | Electricity | 1 | Active |
| US11760782B2 | Peptides and methods for the treatment of diabetes | Human Necessities | 0 | Active |
| US11787849B2 | Methods and compounds for eliminating immune responses to therapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US12023384B2 | Immunogenic peptides comprising an MHC class II T cell epitope and a redox motif | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.